A Pharmacist's Query Avoiding Exacerbation of Adverse Effects in a Patient with Acyclovir Encephalopathy: A Case Report

We report a haemodialysis patient with end-stage renal failure whom a pharmacist aided in the management of acyclovir (ACV) encephalopathy, which may have been related to valacyclovir hydrochloride (VACV) administered without sufficient dose reduction. The patient 78 years was admitted with a tentat...

Full description

Saved in:
Bibliographic Details
Published inYAKUGAKU ZASSHI Vol. 142; no. 7; pp. 771 - 774
Main Authors 渡邊, 政博, 山口, 佳津騎, 黒川, 直弘, 松原, 亜紀, 芳地, 一, 田中, 裕章, 田井, 達也, 小坂, 信二, 新村, 航, 元木, 貴大
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本薬学会 01.07.2022
Pharmaceutical Society of Japan
Subjects
Online AccessGet full text
ISSN0031-6903
1347-5231
1347-5231
DOI10.1248/yakushi.21-00237

Cover

More Information
Summary:We report a haemodialysis patient with end-stage renal failure whom a pharmacist aided in the management of acyclovir (ACV) encephalopathy, which may have been related to valacyclovir hydrochloride (VACV) administered without sufficient dose reduction. The patient 78 years was admitted with a tentative diagnosis of varicella zoster viral meningitis. A pharmacist suspected ACV encephalopathy related to excessive VACV administration and raised a query with the attending physician. According to the pharmacist's proposal, ACV administration was discontinued and continuous hemodiafiltration (CHDF) was performed. On day 5 of hospitalisation, the consciousness disorder was improved. In this report, we showed the detailed CHDF conditions of the present case, and the contribution of a pharmacist to treating and avoiding ACV encephalopathy was discussed.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0031-6903
1347-5231
1347-5231
DOI:10.1248/yakushi.21-00237